Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual
Starting soon · Phase 2
Conditions studied: Opioid Use Disorder
In brief
This study will compare in-person induction and maintenance dosing of sublingual buprenorphine to induction and maintenance dosing of sublingual buprenorphine through comprehensive telehealth sessions and telehealth medication for opioid use disorder (MOUD).
Key facts
- Study ID
- NCT05339256
- Run by
- New York State Psychiatric Institute
- People needed
- 50
- Starts
- 2026-06-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-04-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- meet DSM-5 criteria for OUD
- Voluntarily seeking buprenorphine treatment for OUD
- Able to provide informed consent and comply with study procedures
You may not qualify if…
- Meeting DSM-5 criteria for substance use disorder other than opioid as the primary diagnosis that would compromise safety of participation in the trial as determined by the study physician, such as an alcohol or sedative hypnotic use disorder that requires detoxification
- Having a comorbid psychiatric diagnosis that might interfere with participation or make participation hazardous, such as a psychotic disorder including schizophrenia or schizoaffective disorder
- Concurrent methadone, buprenorphine, or vivitrol maintenance treatment
- Known history of allergy, intolerance, or hypersensitivity to candidate medication (buprenorphine)
- Pregnancy, lactation, or failure to use adequate contraceptive methods in female patients
- Unstable medical conditions, such as severe hepatic, renal, or cardiovascular disease, which might make participation
- Current or recent history history of significant violent or suicidal behavior or risk for suicide or homicide
- Legally mandated to substance use disorder treatment.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.